"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 7 | 1 | 8 |
| 2004 | 10 | 3 | 13 |
| 2005 | 7 | 2 | 9 |
| 2006 | 8 | 2 | 10 |
| 2007 | 12 | 2 | 14 |
| 2008 | 10 | 0 | 10 |
| 2009 | 11 | 3 | 14 |
| 2010 | 20 | 5 | 25 |
| 2011 | 14 | 4 | 18 |
| 2012 | 15 | 6 | 21 |
| 2013 | 19 | 4 | 23 |
| 2014 | 17 | 2 | 19 |
| 2015 | 25 | 1 | 26 |
| 2016 | 36 | 2 | 38 |
| 2017 | 33 | 2 | 35 |
| 2018 | 28 | 5 | 33 |
| 2019 | 36 | 8 | 44 |
| 2020 | 51 | 3 | 54 |
| 2021 | 52 | 4 | 56 |
| 2022 | 43 | 2 | 45 |
| 2023 | 29 | 0 | 29 |
| 2024 | 23 | 10 | 33 |
| 2025 | 30 | 0 | 30 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
The 3P-CP model: Expanding our conceptualization of cancer?pain. Cancer. 2025 Sep 15; 131(18):e70080.
-
The impact of a geriatric assessment-guided management intervention (GAIN-S) on prognostic awareness: A randomized controlled trial. Cancer. 2025 Sep 01; 131(17):e70054.
-
PIK3CB Inhibitor GSK2636771 in Cancers With PTEN Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and P. JCO Precis Oncol. 2025 Aug; 9:e2500265.
-
Long noncoding RNAs regulating enzymatic reactions in cancer. Exp Mol Med. 2025 Aug; 57(8):1641-1650.
-
Uridine as a hub in cancer metabolism and RNA biology. Exp Mol Med. 2025 Aug; 57(8):1651-1662.
-
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicine. Genome Med. 2025 Aug 07; 17(1):87.
-
Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy. Cancer Res Commun. 2025 Aug 01; 5(8):1288-1297.
-
Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid Tumors. JCO Precis Oncol. 2025 Jul; 9:e2500055.
-
Germline POT1 Variants in a Pan-Cancer Cohort. JCO Precis Oncol. 2025 Jul; 9:e2400946.
-
Healthcare professionals' perspectives on improving care coordination between palliative and cancer care for rural older adults: A qualitative study. J Geriatr Oncol. 2025 Sep; 16(7):102301.